NEW YORK--(BUSINESS WIRE)--Sept. 21, 2006--Chembio Diagnostics, Inc. (OTCBB:CEMI) strongly supports the U.S. Centers for Disease Control and Prevention's (CDC) HIV testing final recommendations issued this morning that all Americans between the ages of 13 to 64 be tested for HIV as a part of routine medical care. Today's news comes just as the US Conference on AIDS begins in Hollywood, Florida. At the conference, which runs from September 21-25, Chembio will exhibit its two FDA-approved rapid HIV tests, SURE CHECK(R) HIV 1/2 and HIV 1/2 STAT-PAK(TM), at booth #803.
